Unique Group has secured a significant contract to supply advanced Launch and Recovery Systems for CCC Underwater Engineering’s new flagship vessel. The systems will support operations in the challenging Arabian Gulf environment, with delivery scheduled for early 2026.
New research confirms what many economists predicted: tariffs are directly fueling inflation. The Bank of America analysis provides concrete numbers on how trade policies are affecting consumer prices and business costs.
octonomy’s €18.5 million funding signals a major shift in enterprise AI. Their agentic systems achieve 95% accuracy on complex technical workflows, potentially disrupting how heavy industries handle service and maintenance operations.
The Supreme Court faces a constitutional showdown over presidential tariff powers that could determine $50+ billion in revenue and redefine executive authority in trade policy. Businesses warn of investment paralysis while the administration cites national security imperatives.
China’s manufacturing sector showed unexpected weakness in October as trade tensions with the US intensified. The private PMI reading dropped to 50.6, missing analyst expectations and signaling broader economic headwinds.
Major trade shifts between US and China signal tech détente as Google makes unprecedented AI play in India. Meanwhile, Singapore cracks down on alleged scam operations and Australia investigates insider trading allegations.
Britain’s small businesses are struggling to capitalize on new trade deals, with 84% of micro-enterprises reporting flat or declining exports. The export crisis threatens UK economic growth as government support services face cuts.
The SEC is preparing to scrap quarterly reporting requirements that have governed public companies since 1970. This fundamental shift to semiannual reporting could transform how businesses operate and markets function by 2028.
Pfizer has filed a lawsuit against Novo Nordisk and Metsera over a competing $9 billion bid for the obesity drug developer. The legal battle reveals the escalating war for obesity treatment dominance as pharmaceutical giants scramble for market position.
A Carnegie Mellon professor now holds unprecedented authority over OpenAI’s AI releases. As the company restructures for profit, his safety committee could determine the future of AI deployment.
